Loading…
Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy
Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than o...
Saved in:
Published in: | Progress in neuro-psychopharmacology & biological psychiatry 2006-06, Vol.30 (4), p.565-585 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3 |
container_end_page | 585 |
container_issue | 4 |
container_start_page | 565 |
container_title | Progress in neuro-psychopharmacology & biological psychiatry |
container_volume | 30 |
creator | Lechin, Fuad van der Dijs, Bertha Hernández-Adrián, Gerardo |
description | Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances. |
doi_str_mv | 10.1016/j.pnpbp.2005.11.025 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67912294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S027858460500388X</els_id><sourcerecordid>67912294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</originalsourceid><addsrcrecordid>eNqFkd-q1DAQxosonj1Hn0CQ3ujV2ZpJ0qYreHE4_oUDguh1SNLpNkub1KRb2Hf0oczuVvZG9GpmPn4zDN-XZS-AFECgerMrRjfqsaCElAVAQWj5KFtBLeo1p1A9zlaEpr6seXWVXce4I4QAI-xpdgUVZxUDWGW_3vsQVZ8HNXaYz7HIB2yscosQMfjJOwxba3LlJrX1zsahyO-cmvxgjepv87E7ROt7vz2PGjs1Wx-OvcN98Ogab4J1F-Qkj50KgzJ_1HS-yU1v3WnA2TboDMa3-TfscVapz1sf_r46dZj-PTzLnrSqj_h8qTfZj48fvt9_Xj98_fTl_u5hbXjNp7XSJUBNQJsWRFm3TIi6VIS1jHHSbjS2QtecmLbiNWihlGEN0yWpFKGGaMNustfnu2PwP_cYJznYaLDvlUO_j7ISG6B0w_8LggDBakESyM6gCT7GgK0cgx1UOEgg8pi23MlT2vKYtgSQKe209XI5v9cptsvOEm8CXi2AismnNiQbbbxwQnDKKE3cuzOHybXZYpDR2KP9jQ1oJtl4-89HfgPF3s_J</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17173870</pqid></control><display><type>article</type><title>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</title><source>ScienceDirect Freedom Collection</source><creator>Lechin, Fuad ; van der Dijs, Bertha ; Hernández-Adrián, Gerardo</creator><creatorcontrib>Lechin, Fuad ; van der Dijs, Bertha ; Hernández-Adrián, Gerardo</creatorcontrib><description>Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2005.11.025</identifier><identifier>PMID: 16436311</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>5-HT-1A receptors ; 5-HT-1B/D receptors ; Adult and adolescent clinical studies ; Animals ; Behavior - drug effects ; Behavior - physiology ; Biological and medical sciences ; Catecholamines - pharmacology ; Central serotonergic system ; Depression ; Depression and psychotic circuitries ; Dorsal raphe ; Humans ; Major depression and dysthymic depression ; Median raphe ; Medical sciences ; Mood disorders ; Neural Pathways - anatomy & histology ; Neural Pathways - drug effects ; Neural Pathways - physiology ; Neuroendocrinology ; Neuropharmacology ; Neurophysiology ; Pharmacology. Drug treatments ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Raphe Nuclei - anatomy & histology ; Raphe Nuclei - drug effects ; Raphe Nuclei - physiology ; Serotonin Antagonists - pharmacology</subject><ispartof>Progress in neuro-psychopharmacology & biological psychiatry, 2006-06, Vol.30 (4), p.565-585</ispartof><rights>2005 Elsevier Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</citedby><cites>FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17742322$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16436311$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lechin, Fuad</creatorcontrib><creatorcontrib>van der Dijs, Bertha</creatorcontrib><creatorcontrib>Hernández-Adrián, Gerardo</creatorcontrib><title>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</title><title>Progress in neuro-psychopharmacology & biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.</description><subject>5-HT-1A receptors</subject><subject>5-HT-1B/D receptors</subject><subject>Adult and adolescent clinical studies</subject><subject>Animals</subject><subject>Behavior - drug effects</subject><subject>Behavior - physiology</subject><subject>Biological and medical sciences</subject><subject>Catecholamines - pharmacology</subject><subject>Central serotonergic system</subject><subject>Depression</subject><subject>Depression and psychotic circuitries</subject><subject>Dorsal raphe</subject><subject>Humans</subject><subject>Major depression and dysthymic depression</subject><subject>Median raphe</subject><subject>Medical sciences</subject><subject>Mood disorders</subject><subject>Neural Pathways - anatomy & histology</subject><subject>Neural Pathways - drug effects</subject><subject>Neural Pathways - physiology</subject><subject>Neuroendocrinology</subject><subject>Neuropharmacology</subject><subject>Neurophysiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Raphe Nuclei - anatomy & histology</subject><subject>Raphe Nuclei - drug effects</subject><subject>Raphe Nuclei - physiology</subject><subject>Serotonin Antagonists - pharmacology</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkd-q1DAQxosonj1Hn0CQ3ujV2ZpJ0qYreHE4_oUDguh1SNLpNkub1KRb2Hf0oczuVvZG9GpmPn4zDN-XZS-AFECgerMrRjfqsaCElAVAQWj5KFtBLeo1p1A9zlaEpr6seXWVXce4I4QAI-xpdgUVZxUDWGW_3vsQVZ8HNXaYz7HIB2yscosQMfjJOwxba3LlJrX1zsahyO-cmvxgjepv87E7ROt7vz2PGjs1Wx-OvcN98Ogab4J1F-Qkj50KgzJ_1HS-yU1v3WnA2TboDMa3-TfscVapz1sf_r46dZj-PTzLnrSqj_h8qTfZj48fvt9_Xj98_fTl_u5hbXjNp7XSJUBNQJsWRFm3TIi6VIS1jHHSbjS2QtecmLbiNWihlGEN0yWpFKGGaMNustfnu2PwP_cYJznYaLDvlUO_j7ISG6B0w_8LggDBakESyM6gCT7GgK0cgx1UOEgg8pi23MlT2vKYtgSQKe209XI5v9cptsvOEm8CXi2AismnNiQbbbxwQnDKKE3cuzOHybXZYpDR2KP9jQ1oJtl4-89HfgPF3s_J</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Lechin, Fuad</creator><creator>van der Dijs, Bertha</creator><creator>Hernández-Adrián, Gerardo</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20060601</creationdate><title>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</title><author>Lechin, Fuad ; van der Dijs, Bertha ; Hernández-Adrián, Gerardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>5-HT-1A receptors</topic><topic>5-HT-1B/D receptors</topic><topic>Adult and adolescent clinical studies</topic><topic>Animals</topic><topic>Behavior - drug effects</topic><topic>Behavior - physiology</topic><topic>Biological and medical sciences</topic><topic>Catecholamines - pharmacology</topic><topic>Central serotonergic system</topic><topic>Depression</topic><topic>Depression and psychotic circuitries</topic><topic>Dorsal raphe</topic><topic>Humans</topic><topic>Major depression and dysthymic depression</topic><topic>Median raphe</topic><topic>Medical sciences</topic><topic>Mood disorders</topic><topic>Neural Pathways - anatomy & histology</topic><topic>Neural Pathways - drug effects</topic><topic>Neural Pathways - physiology</topic><topic>Neuroendocrinology</topic><topic>Neuropharmacology</topic><topic>Neurophysiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Raphe Nuclei - anatomy & histology</topic><topic>Raphe Nuclei - drug effects</topic><topic>Raphe Nuclei - physiology</topic><topic>Serotonin Antagonists - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lechin, Fuad</creatorcontrib><creatorcontrib>van der Dijs, Bertha</creatorcontrib><creatorcontrib>Hernández-Adrián, Gerardo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lechin, Fuad</au><au>van der Dijs, Bertha</au><au>Hernández-Adrián, Gerardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy</atitle><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>30</volume><issue>4</issue><spage>565</spage><epage>585</epage><pages>565-585</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Monoaminergic neurons located in the central nervous system (CNS) are organized into complex circuits which include noradrenergic (NA), adrenergic (Ad), dopaminergic (DA), serotonergic (5-HT), histaminergic (H), GABA-ergic and glutamatergic systems. Most of these circuits are composed of more than one and often several types of the above neurons. Such physiologically flexible circuits respond appropriately to both external and internal stimuli which, if not modulated adequately, can trigger pathophysiologic responses. A great deal of research has been devoted to mapping the multiple functions of the CNS circuitry, thereby forming the basis for effective neuropharmacological therapeutic approaches. Such lineal strategies that seek to normalize complex and mixed physiological disorders, however, meet only partial therapeutic success and are often followed by undesirable side effects and/or total failure. In light of these, we have worked to develop possible models of CNS circuitry that are less affected by physiological interaction using the models to design more effective therapeutic approaches. In the present review, we cite and present evidence supporting the dorsal raphe versus median raphe serotonergic circuitry as one model of a reliable paradigm, necessary to the clear understanding and therapy of many psychiatric and even non-psychiatric disturbances.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>16436311</pmid><doi>10.1016/j.pnpbp.2005.11.025</doi><tpages>21</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-5846 |
ispartof | Progress in neuro-psychopharmacology & biological psychiatry, 2006-06, Vol.30 (4), p.565-585 |
issn | 0278-5846 1878-4216 |
language | eng |
recordid | cdi_proquest_miscellaneous_67912294 |
source | ScienceDirect Freedom Collection |
subjects | 5-HT-1A receptors 5-HT-1B/D receptors Adult and adolescent clinical studies Animals Behavior - drug effects Behavior - physiology Biological and medical sciences Catecholamines - pharmacology Central serotonergic system Depression Depression and psychotic circuitries Dorsal raphe Humans Major depression and dysthymic depression Median raphe Medical sciences Mood disorders Neural Pathways - anatomy & histology Neural Pathways - drug effects Neural Pathways - physiology Neuroendocrinology Neuropharmacology Neurophysiology Pharmacology. Drug treatments Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Raphe Nuclei - anatomy & histology Raphe Nuclei - drug effects Raphe Nuclei - physiology Serotonin Antagonists - pharmacology |
title | Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T02%3A01%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dorsal%20raphe%20vs.%20median%20raphe%20serotonergic%20antagonism.%20Anatomical,%20physiological,%20behavioral,%20neuroendocrinological,%20neuropharmacological%20and%20clinical%20evidences:%20Relevance%20for%20neuropharmacological%20therapy&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Lechin,%20Fuad&rft.date=2006-06-01&rft.volume=30&rft.issue=4&rft.spage=565&rft.epage=585&rft.pages=565-585&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2005.11.025&rft_dat=%3Cproquest_cross%3E67912294%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-ab511801bcf1758f37785a03f3340f9bef7b840cf6481b7aac3d3b506a02c0bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17173870&rft_id=info:pmid/16436311&rfr_iscdi=true |